Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
We have surveyed the incidence of adult T‐cell leukemia/lymphoma (ATLL) in an endemic area of 290,464 inhabitants for 7 years. We now revise our previous results on the basis of additional findings and estimate the age‐ and sex‐specific cumulative rate for HTLV‐I carriers, the adoption of which is recommended by current cancer epidemiology as a new age‐standardized incidence rate. An unequivocal age‐dependent increase in seroprevalence was observed for both sexes with a characteristic predominance in females. The age‐dependent seroconversion in females may be partly explained by additional infection from infected husbands to their wives but the reason for men remains obscure. The mean annual number of incident cases of ATLL was 11.4, giving 3.9 ATLL patients annually per 10 5 inhabitants, 6.1 per 10 5 inhabitants aged over 30, and 85.0 per 10 5 seropositives aged over 30. Crude annual incidence rate of ATLL among 10 5 male seropositives aged over 30 was 145.3 and that for females was 55.2 and 95% confidence intervals of ATLL incidence rates were 34.8 to 255.7 for males and 6.4 to 104.1 for females, respectively. Although the sex ratio of 80 ATLL patients was 1.35, males are more prone to the disease (46 male patients among 4,522 male seropositives aged over 30 vs. 34 female patients among 8,801 female seropositives aged over 30; p < 0.001) for unknown reason(s). Morbidity in male seropositives aged over 30 is 2.6 times as high as that of females. Decennial incidence rates in males in their fifties and sixties were significantly higher than those in females. The remarkable male preponderance in oncogenicity of HTLV‐I may be due to the fact that men are more prone to the disease and the number of female carriers in the denominator used to calculate the incidence rate is larger than that of males. The whole life span (0–79) cumulative risk for males was 6.9% and significantly higher than that of females (2.95%).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Approximately 5% of HTLV-1 patients are at risk of developing ATL, an aggressive mature T cell malignancy [104,191].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [191]
Citations
Cites
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Hinuma, Y., Komoda, H., Chosa, T., Kondo, T., Kohakura, M., Takenaka, T., Kikuchi, M., Ichimaru, M., Yunoki, K., Sato, I., et al. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910290606 · Cited by 591
Self-citationIntrafamilial Transmission of Adult T Cell Leukemia Virus
Kajiyama, W., Kashiwagi, S., Ikematsu, H., Hayashi, J., Nomura, H., & Okochi, K. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.5.851 · Cited by 314
Maeda, Y., Furukawa, M., Takehara, Y., Yoshimura, K., Miyamoto, K., Matsuura, T., Morishima, Y., Tajima, K., Okochi, K., & Hinuma, Y. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330602 · Cited by 136
Self-citationTokudome, S., Tokunaga, O., Shimamoto, Y., Miyamoto, Y., Sumida, I., Kikuchi, M., Takeshita, M., Ikeda, T., Fujiwara, K., & Yoshihara, M. (1989) · PubMed · Cited by 123
Estimation of Rate of Incidence of ATL Among ATLV (HTLV-I) Carriers in Kyushu, Japan
TAJIMA, K., & Kuroishi, M. (1985) · Japanese Journal of Clinical Oncology · doi:10.1093/oxfordjournals.jjco.a039062 · Cited by 113
Oshima, A., Tsukuma, H., Hiyama, T., Fujimoto, I., Yamano, H., & Tanaka, M. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340607 · Cited by 103
Tajima, K., Kamura, S., Ito, S., Ito, M., Nagatomo, M., Kinoshita, K., & Ikeda, S. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400605 · Cited by 102
Sakuma, K., Takahara, T., Okuda, K., Tsuda, F., & Mayumi, M. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80294-1 · Cited by 74
MORTALITY OF HEPATITIS B POSITIVE BLOOD DONORS IN ENGLAND AND WALES
Hall, A. J., Winter, P. D., & Wright, R. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91976-2 · Cited by 68
Research works printed but not linked: 6
- Beasley R. P., 1982, Hepatitis B virus as the etiologic agent in hepatocellular carcinoma—epidemiologic considerations, Hepatology, 2, 21
- Kinoshita K., 1985, Annual incidence of adult T‐Cell leukemia‐Lymphoma (aTLL) from ATL virus‐Carriers in Nagasaki Prefecture, Nagasaki Igakkai Zasshi, 60, 56
- Kondo T., 1987, Risk of adult T‐Cell leukemia/Lymphoma in HTLV‐I carriers, Lancet, 18
- Kondo T., 1985, Epidemiology of ATLL and preceding stages, Rec. Advanc. RES Res., 25, 156
- Prince A. M., 1982, The risk of development of hepatocellular carcinoma in hepatitis B virus carriers in New York. A preliminary estimate using death‐Records matching, Hepatology, 2, 15
- Tajima K., 1982, Epidemiological analysis of the distribution of antibody to adult T‐Cell leukemia‐Virus‐Associated antigen (aTLA): possible horizontal transmission of adult T‐Cell leukemia virus, Gann, 73, 893
Cited by
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Dougan, M., & Dranoff, G. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132544 · Cited by 607
Cancer and infection: estimates of the attributable fraction in 1990.
Pisani, P., Parkin, D. M., Muñóz, N., & Ferlay, J. (1997) · PubMed · Cited by 448
Human T-lymphotropic virus type I infection
Manns, A., Hisada, M., & Grenade, L. L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09460-4 · Cited by 360
Tajima, K., The T‐ and B‐Cell Malignancy Study Group, & Co‐Authors (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450206 · Cited by 305
Adult T-Cell Leukemia: A Review of Epidemiological Evidence
Iwanaga, M., Watanabe, T., & Yamaguchi, K. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00322 · Cited by 255
Human T-lymphotropic virus type I in Japan
Yamaguchi, K. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90994-6 · Cited by 213
An Update of the Epidemiology of Non-Hodgkin's Lymphoma
Chiu, B. C.-H., & Weisenburger, D. D. (2003) · Clinical Lymphoma · doi:10.3816/clm.2003.n.025 · Cited by 179
Rafatpanah, H., Hedayati-Moghaddam, M. R., Fathimoghadam, F., Bidkhori, H. R., Shamsian, S. K., Ahmadi, S., Sohgandi, L., Azarpazhooh, M. R., Rezaee, S. A., Farid, R., et al. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.07.004 · Cited by 178
Arisawa, K., Soda, M., Endo, S., Kurokawa, K., Katamine, S., Shimokawa, I., Koba, T., Takahashi, T., Saito, H., Doi, H., et al. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000201)85:3<319::aid-ijc4>3.0.co;2-b · Cited by 141
Inflammatory manifestations of HTLV-1 and their therapeutic options
Martin, F., Taylor, G. P., & Jacobson, S. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.966690 · Cited by 147
Bangham, C. R. M. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.8.581 · Cited by 145
Epidemiology and Etiology of Non-Hodgkin Lymphoma
Chiu, B. C. ‐., & Hou, N. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-13150-4_1 · Cited by 142
Epidemiology of HTLV-1 Infection and ATL in Japan: An Update
Iwanaga, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01124 · Cited by 118
Sullivan, M., Williams, A. E., Fang, C. T., Grandinetti, T., Poiesz, B. J., & Ehrlich, G. E. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400100115019 · Cited by 116
Tsukasaki, K., Miller, C. W., Kubota, T., Takeuchi, S., Fujimoto, T., Ikeda, S., Tomonaga, M., & Koeffler, H. P. (2001) · PubMed · Cited by 90
Murphy, E. L., Glynn, S. A., Fridey, J., Smith, J. W., Sacher, R. A., Nass, C. C., Ownby, H. E., Wright, D. J., & Nemo, G. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.13.1485 · Cited by 84
Human T lymphotropic virus type 1 uveitis.
Mochizuki, M., Tajima, K., Watanabe, T., & Yamaguchi, K. (1994) · British Journal of Ophthalmology · doi:10.1136/bjo.78.2.149 · Cited by 78
Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation
Lairmore, M. D., Silverman, L. R., & Ratner, L. (2005) · Oncogene · doi:10.1038/sj.onc.1208974 · Cited by 76
An animal model of adult T-cell leukemia: humanized mice with HTLV-1–specific immunity
Tezuka, K., Xun, R., Tei, M., Ueno, T., Tanaka, M., Takenouchi, N., & Fujisawa, J.-I. (2014) · Blood · doi:10.1182/blood-2013-06-508861 · Cited by 68
Human T-cell lymphotropic virus type-1: a lifelong persistent infection, yet never truly silent
Hirons, A., Khoury, G., & Purcell, D. F. J. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30328-5 · Cited by 56
HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact
Pinto, D. O., DeMarino, C., Pleet, M. L., Cowen, M., Branscome, H., Al Sharif, S., Jones, J., Dutartre, H., Lepene, B., Liotta, L. A., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02147 · Cited by 64
“Human T-cell leukemia virus-1 is associated with Adult T-cell leukemia/lymphoma [ATLL; 3–5% (Hinuma et al., 1981; Poiesz et al., 1981; Aoki et al., 1984; Kondo et al., 1989; Hirai et al., 1992; Iwanaga et al., 2012; Coffin, 2015; Tagaya and Gallo, 2017)] and HTLV-1 associated myelopathy/tropical spastic paraparesis [H…”
Background10 Adult T cell leukaemia-lymphoma
Yamaguchi, K., & Takatsuki, K. (1993) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80183-0 · Cited by 60
Hasegawa, A., Ohashi, T., Hanabuchi, S., Kato, H., Takemura, F., Masuda, T., & Kannagi, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.5.2956-2963.2003 · Cited by 53
Human Retroviruses: HTLV-I and HTLV-II
Sugamura, K., & Hinuma, Y. (1993) · Springer eBooks · doi:10.1007/978-1-4899-1627-3_7 · Cited by 55
Self-citationHTLV-1 in Solid-Organ Transplantation: Current Challenges and Future Management Strategies
Armstrong, M. J., Corbett, C. J., Rowe, I. A. C., Taylor, G. P., & Neuberger, J. (2012) · Transplantation · doi:10.1097/tp.0b013e318263ad7a · Cited by 54
Satake, M., Yamada, Y., Atogami, S., & Yamaguchi, K. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.964700 · Cited by 53
High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease
Honarbakhsh, S., & Taylor, G. P. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1002-0 · Cited by 51
Coler-Reilly, A. L. G., Yagishita, N., Suzuki, H., Sato, T., Araya, N., Inoue, E., Takata, A., & Yamano, Y. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0451-x · Cited by 44
T-cell lymphomas, a challenging disease: types, treatments, and future
Ma, H., & Abdul‐Hay, M. (2016) · International Journal of Clinical Oncology · doi:10.1007/s10147-016-1045-2 · Cited by 48
Ikeda, S., Momita, S., Kinoshita, K.-I., Kamihira, S., Moriuchi, Y., Tsukasaki, K., Ito, M., Kanda, T., Moriuchi, R., & Nakamura, T. (1993) · Blood · doi:10.1182/blood.v82.7.2017.2017 · Cited by 47
Genome editing and the next generation of antiviral therapy
Stone, D., Niyonzima, N., & Jerome, K. R. (2016) · Human Genetics · doi:10.1007/s00439-016-1686-2 · Cited by 46
Rosadas, C., Brites, C., Arakaki-Sánchez, D., Casseb, J., & Ishak, R. (2021) · Epidemiologia e Serviços de Saúde · doi:10.1590/s1679-497420200006000015.esp1 · Cited by 44
Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread
Pinto, D. O., Sharif, S. A., Mensah, G. A., Cowen, M., Khatkar, P., Erickson, J. W., Branscome, H., Lattanze, T., DeMarino, C., Alem, F., et al. (2021) · Retrovirology · doi:10.1186/s12977-021-00550-8 · Cited by 40
Rosadas, C., Brites, C. R., Arakaki-Sánchez, D., Casseb, J., & Ishak, R. (2021) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-605-2020 · Cited by 40
Hisada, M., Okayama, A., Spiegelman, D. L., Mueller, N. E., & Stuver, S. O. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010215)91:4<497::aid-ijc1044>3.0.co;2-a · Cited by 38
Ohshima, K., Mukai, Y., Shiraki, H., Suzumiya, J., Tashiro, K., & Kikuchi, M. (1997) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199704)54:4<306::aid-ajh8>3.0.co;2-z · Cited by 36
Gérard, Y., Lepère, J., Pradinaud, R., Joly, F., Lepelletier, L., Joubert, M., Marie, D. S., Mahieux, R., Ureta‐Vidal, A., Larregain-Fournier, D., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600607 · Cited by 36
Adult T‐cell leukaemia lymphoma in an Aborigine
Kirkland, M. A., Frasca, J., & Bastian, I. (1991) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1991.tb01380.x · Cited by 36
Chadburn, A., Athan, E. S., Wieczorek, R. L., & Knowles, D. (1991) · Blood · doi:10.1182/blood.v77.11.2419.2419 · Cited by 36
TACHIBANA, N., Okayama, A., Ishihara, S., Shioiri, S., Murai, K., Tsuda, K., Goya, N., Matsuo, Y., Essex, M., Stuver, S. O., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510415 · Cited by 35
Cruickshank, J. K., Richardson, J. H., Morgan, O., Porter, J. C., Klenerman, P., Knight, J., Newell, A., Rudge, P., & Dalgleish, A. G. (1990) · BMJ · doi:10.1136/bmj.300.6720.300 · Cited by 35
Trends in HTLV‐1 prevalence and incidence of adult T‐cell leukemia/lymphoma in Nagasaki, Japan
Koga, Y., Iwanaga, M., Soda, M., Inokuchi, N., Sasaki, D., Hasegawa, H., Yanagihara, K., Yamaguchi, K., Kamihira, S., & Yamada, Y. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21738 · Cited by 32
“…a higher level of prevalence was found in females, which has been documented previously and was interpreted as showing that HTLV-1 is transmitted more easily from husband to wife than from wife to husband [Tajima et al., 1987; Kondo et al., 1989; Tokudome et al., 1989; Yamaguchi et al., 1992].”
ResultInfluentialWeber, T., Hunsmann, G., Stevens, W., & Fleming, A. F. (1992) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(11)80021-1 · Cited by 32
Rafatpanah, H., Farid, R., Golanbar, G., & Azad, F. J. (2006) · PubMed · Cited by 29
Human T-lymphotropic virus type 1 infection
Tsukasaki, K., Koeffler, H. P., & Tomonaga, M. (2000) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.1999.0070 · Cited by 29
Kozuru, M., Uike, N., Muta, K., Goto, T., Suehiro, Y., & Nagano, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960901)78:5<1119::aid-cncr24>3.0.co;2-4 · Cited by 28
Prevention of Human T-Cell Lymphotropic Virus Type 1 Infection and Adult T-Cell Leukemia/Lymphoma
Yoshimitsu, M., White, Y., & Arima, N. (2013) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-38965-8_12 · Cited by 26
Kalavi, K., Moradi, A., & Tabarraei, A. (2013) · PubMed Central · Cited by 25
Adult T-cell leukemia–lymphoma
Tsukasaki, K. (2012) · Hematology · doi:10.1179/102453312x13336169155330 · Cited by 25
Human T‐Cell Lymphotrophic Virus Infection in Organ Donors: A Need to Reassess Policy?
Shames, B. D., D’Alessandro, A. M., & Sollinger, H. W. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20712.x · Cited by 25
Evolution of mutation rate and virulence among human retroviruses
Ewald, P. W. (1994) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1994.0150 · Cited by 25
Extracellular Vesicles in HTLV-1 Communication: The Story of an Invisible Messenger
Sharif, S. A., Pinto, D. O., Mensah, G. A., Dehbandi, F., Khatkar, P., Kim, Y., Branscome, H., & Kashanchi, F. (2020) · Viruses · doi:10.3390/v12121422 · Cited by 24
Current State of Therapeutics for HTLV-1
Wang, T. T., Hirons, A., Doerflinger, M., Morris, K. V., Ledger, S., Purcell, D. F. J., Kelleher, A. D., & Ahlenstiel, C. L. (2024) · Viruses · doi:10.3390/v16101616 · Cited by 22
“Previous sections have outlined the lack of specific and targeted treatments for HTLV-1 inflammatory and immune related conditions, which is mirrored in the treatment of other associated inflammatory diseases and secondary infections.”
BackgroundMortality among Inhabitants of an HTLV‐I Endemic Area in Japan
Iwata, K., Shinichiro, I. T. O., Saito, H., Ito, M., Nagatomo, M., Yamasaki, T., Yoshida, S., Suto, H., & Tajima, K. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02087.x · Cited by 22
Cancer burden and trends in the Asian Pacific Rim region.
Yang, B. H., Parkin, D. M., Cai, L., & Zhang, Z. (2004) · PubMed · Cited by 21
Retroviruses—Human T-Cell Lymphotropic Virus
Mueller, N. E., & Blattner, W. A. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0036-4_25 · Cited by 19
Tokunaga, M., Uto, H., Oda, K., Tokunaga, M., Mawatari, S., Kumagai, K., Haraguchi, K., Oketani, M., Ido, A., Ohnou, N., et al. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-013-0928-5 · Cited by 18
“Antivirals” in the Treatment of Adult T Cell Leukaemia– Lymphoma (ATLL)
Fields, P. A., & Taylor, G. P. (2012) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-012-0139-9 · Cited by 18
Hisada, M., Stuver, S. O., Okayama, A., & Mueller, N. E. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-199911010-00013 · Cited by 18
Molecular detection of pre‐atl state among healthy HTLV‐1 carriers in an endemic area of Japan
Ghen, Y., Jkeda, S., Mori, H., Hata, T., Tsukasaki, K., Momita, S., Yamada, Y., Kamihira, S., Mine, M., & Tomonaga, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600612 · Cited by 17
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma
Phillips, A. A. (2022) · Current Opinion in Virology · doi:10.1016/j.coviro.2022.101289 · Cited by 16
Risk of Adult T-cell Leukemia Developing Individuals with HTLV-I Infection
Kamihira, S., Yamada, Y., Ikeda, S., Atogami, S. M. S., Sohda, H., Tomonaga, M., & Tokudome, S. (1992) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199209053580 · Cited by 15
Cancer burden and trends in the asian pacific RIM region
Yang, B., Parkin, D. M., Cai, L., & Zhang, Z. F. (2004) · Annals of Epidemiology · doi:10.1016/j.annepidem.2004.07.013 · Cited by 13
Komori, K., Hasegawa, A., Kurihara, K., Honda, T., Yokozeki, H., Masuda, T., & Kannagi, M. (2006) · Journal of Virology · doi:10.1128/jvi.00230-06 · Cited by 13
Adult T-cell leukemia/lymphoma—pathobiology and implications for modern clinical management
Cook, L. B. M., Rowan, A. G., & Bangham, C. R. M. (2021) · Annals of Lymphoma · doi:10.21037/aol-21-6 · Cited by 12
Clinical Applications of Genomic Alterations in ATLL: Predictive Markers and Therapeutic Targets
Yoshida, N., Miyoshi, H., & Ohshima, K. (2021) · Cancers · doi:10.3390/cancers13081801 · Cited by 11
Mueller, N. E., Birmann, B. M., Parsonnet, J., SCHIFFMAN, M. H., & Stuver, S. O. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0026 · Cited by 11
Takezaki, T., Hirose, K., Hamajima, N., Kuroishi, T., & Tajima, K. (1997) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/27.3.140 · Cited by 10
Tezuka, K., Okuma, K., Kuramitsu, M., Matsuoka, S., Tanaka, R., Tanaka, Y., & Hamaguchi, I. (2017) · Journal of Virology · doi:10.1128/jvi.01885-17 · Cited by 9
ACUTE ADULT T‐CELL LEUKEMIA/LYMPHOMA PRESENTING WITH FLORID CUTANEOUS DISEASE
WRIGHT, S. A., Rothe, M. J., Sporn, J., Voorhees, A. S. V., & Grant-Kels, J. M. (1992) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1992.tb02725.x · Cited by 9
Follow-up of asymptomatic HTLV-I carriers among blood donors in Kyushu, Japan
Tokudome, S., Maeda, Y., Fukada, K., Teshima, D., Asakura, T., Sueoka, E., Motomura, Y., Kusumoto, Y., Imamura, Y., Kiyokawa, T., et al. (1991) · Cancer Causes & Control · doi:10.1007/bf00053124 · Cited by 8
Rapidly fatal HTLV-1-associated T-cell leukemia/lymphoma in a patient with SLE
Fritsch-Stork, R. D. E., Leguit, R. J., & Derksen, R. H. W. M. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.49 · Cited by 7
Review Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma
Hibner, U., & Grégoire, D. (2015) · Współczesna Onkologia · doi:10.5114/wo.2014.47132 · Cited by 7
T-Cell Leukemia - Characteristics, Treatment and Prevention
Tomita, M. (2013) · InTech eBooks · doi:10.5772/45997 · Cited by 6
Machigashira, K., Ijichi, S., Nagai, M., Yamano, Y., Hall, W. W., & Osame, M. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)05360-4 · Cited by 6
Quintana, M., Villalobos, J., Domínguez, M. C., Tamayo, Ó., & Vallejo, F. G. (2004) · Colombia medica · doi:10.25100/cm.v35i.1.283 · Cited by 6
SPORADIC HTLV‐I ASSOCIATED ADULT T‐CELL LEUKAEMIA (ATL) IN THE U.K.
Wyld, P. J., Tosswill, J. H. C., Mortimer, P. P., & Weber, J. N. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07852.x · Cited by 6
Sagara, Y., Inoue, Y., Ohshima, K., Kojima, E., Utsunomiya, A., Tsujimura, M., Shiraki, H., & Kashiwagi, S. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00370.x · Cited by 5
Human T-cell lymphotrophic virus type-I (HTLV-I) retrovirus and human disease
Bentrem, D. J., McGovern, E. E., Hammarskjöld, M., & Edlich, R. F. (1994) · Journal of Emergency Medicine · doi:10.1016/0736-4679(94)90491-x · Cited by 5
HTLV‐I and blood safety: let the community decide
Kaldor, J. M. (1997) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1997.tb123214.x · Cited by 5
Adult T-Cell Leukemia-Lymphoma
Tsukasaki, K., Watanabe, T., & Tobinai, K. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00108-9 · Cited by 4
Adult T-Cell Leukemia-Lymphoma
Tobinai, K., & Watanabe, T. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50118-4 · Cited by 4
Prevention of Human T-Cell Lymphotropic Virus Infection and Adult T-Cell Leukemia
Yoshimitsu, M., Kozako, T., & Arim, N. (2013) · InTech eBooks · doi:10.5772/55427 · Cited by 4
Goto, N., Uchida, K., Tomosugi, T., Futamura, K., Okada, M., Hiramitsu, T., Narumi, S., & Watarai, Y. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13314 · Cited by 3
Nakamura‐Hoshi, M., Nomura, T., Nishizawa, M., Hau, T. T. T., Yamamoto, H., Okazaki, M., Ishii, H., Yonemitsu, K., Suzaki, Y., Ami, Y., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01518-23 · Cited by 3
Extracellular vesicles in the pathogenesis of neurotropic viruses
Wu, J., Mao, K., Zhang, R., & Fu, Y. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106901 · Cited by 3
Lahoud, O. B., Moskowitz, A. J., Horwitz, S. M., Giralt, S., & Dahi, P. B. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-017-0086-0 · Cited by 3
Adult T-Cell Leukemia/Lymphoma
Lunning, M. A., Mehta–Shah, N., & Horwitz, S. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00105-5 · Cited by 3
Inouye, M. M. Z., Morimoto, H. K., Morimoto, A. A., Bortoliero, A. L., & de Carvalho, R. A. (1999) · Semina Ciências Biológicas e da Saúde · doi:10.5433/1679-0367.1999v20n2p11 · Cited by 3
Human T-lymphotrophic virus—a neglected cause of chronic pain?
Kemp, H. I., Rice, A. S. C., Adonis, A., Davies, N. W. S., & Taylor, G. P. (2018) · Pain · doi:10.1097/j.pain.0000000000001214 · Cited by 3
5 Management of histologically aggressive lymphomas with a high risk of CNS disease
Horak, I. D., Kremer, A. B., & MAGRATH, I. T. (1996) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(96)80050-3 · Cited by 3
Adult T cell leukaemia lymphoma in a non‐Aboriginal Australian woman with no apparent risk factors
Tong, M. K., Wolf, M. M., & Juneja, S. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb137583.x · Cited by 3
Mistro, A. D., Calabrò, M. L., Favero, A., & Chieco‐Bianchi, L. (1994) · Tumori Journal · doi:10.1177/030089169408000202 · Cited by 3
Yuan, C., Sun, L., Chuang, S., Karube, K., Yang, H., Lee, S., Wang, R. Y., Chang, K., Kao, C., Huang, H., et al. (2025) · The Journal of Pathology Clinical Research · doi:10.1002/2056-4538.70072 · Cited by 2
de Assis, I. M., Domingues, M. M., Almeida, D. D. S., Covre, L. D. S. C., de La‐Roque, D. G. L., Silva, I. C., Nobre, A. F. S., Borges, M. D. S., Pereira, C. C. C., Santana, B. B., et al. (2021) · Research Society and Development · doi:10.33448/rsd-v10i3.13264 · Cited by 2
Altaf, F., Qureshi, Z. A., Moore, S., Golek, T.-M., & Chawala, A. (2023) · Cureus · doi:10.7759/cureus.49169 · Cited by 2
HTLV-1-Associated T-cell Diseases
Tsukasaki, K., & Tobinai, K. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-170-7_8 · Cited by 2
Birckhead, B. J., Peterson, J., Patel, A. B., & Miller, R. C. (2015) · Rare Tumors · doi:10.4081/rt.2015.5834 · Cited by 2
Molecular genetic biomarkers in hematological malignancies
Bagg, A., & Cossman, J. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1996)25+<165::aid-jcb23>3.0.co;2-m · Cited by 2
Metadata
- Authors
- Kondo, T., Kono, H., Miyamoto, N., Yoshida, R., Toki, H., Matsumoto, I., Hara, M., Inoue, H., Inatsuki, A., Funatsu, T., Yamano, N., Bando, F., Iwao, E., Miyoshi, I., Hinuma, Y., & Hanaoka, M.
- Affiliations
- University of Kochi (JP)
- Shionogi (Japan) (JP)
- Kyoto University (JP)
- Corresponding author
- Kondo, Toshifumi
- ORCID
- Matsumoto, Isao
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1989-06-15
- Volume
- 43
- Issue
- 6
- Pages
- 1061-1064
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1981664147
- Cited by
- 118
- References
- 15
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 7 · 2020: 6 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 4 · 2012: 5
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- adult T-cell leukemia/lymphoma, HTLV-1 infection, age-standardized incidence rate, cumulative incidence, sex differences, age-specific incidence, seroconversion, seroprevalence, male preponderance, oncogenicity, endemic areas
- MeSH terms
- Age Factors, Carrier State, Humans, Japan, Population Surveillance, Retrospective Studies, Risk Factors, Sex Factors, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Antibodies, HTLV-I Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.